MarketsStocksKIMIABL
KI

Kimia Biosciences Ltd

NSE: KIMIABLBSE: 530313Healthcare
Download Research Report7-page PDF
34.30
-2.28%
NSE · auto-updates while market open
Mkt Cap
₹17 Cr
P / E
2.2
P / B
0.9
ROE
53.7%
52W High
₹86.85
52W Low
₹23.20
Key Metrics
Market Cap
₹17 Cr
P / E
2.24
P / B
0.94
EV / EBITDA
3.53
ROCE
25.3%
ROE
53.7%
Debt / Equity
1.95
Book Value
₹37.45
EPS
₹1.64
Div Yield
0.0%
Face Value
-
Promoter Holding
74.9%
Revenue · ₹ Cr
106
FY20
133
FY21
125
FY22
129
FY23
105
FY24
119
FY25
115
FY26
Net Profit · ₹ Cr
1
5
10
7
-4
-9
-5
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.3
₹1.1
₹2.0
₹1.6
₹-0.8
₹-2.0
₹-1.1
FY20FY21FY22FY23FY24FY25FY26
Q1 2026 snapshot
Sales
₹28 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.15
Scorecard · 7 axes
Quality
Strong
78/100
Valuation
Strong
2.2×
Growth
Avg
+7.9%
Profitability
Strong
39.5%
Performance
Bad
-26.5%
Entry Point
Strong
39%
Red Flags
Avg
1 flag
Shareholding Pattern
74.9%Promoter
Promoter74.9%
DII0.4%
Public24.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue30.5238.6924.4333.6730.228.21
Net Profit4.571.9920.6041.0155.4420.373
NPM %15.0%5.1%2.5%3.0%18.0%1.3%
AlertPre-trade